SIM
SGMO

Spark Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Spark Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-26,000
Closed -$494K – 717
2018
Q1 		$494K Sell
26,000
-60,500
-70% -$1.29M 0.03% 402
2017
Q4 		$1.42M Buy
+86,500
New +$1.29M 0.08% 322
2016
Q2 		– Sell
-78,100
Closed -$472K – 833
2016
Q1 		$472K Buy
+78,100
New +$469K 0.05% 451
2015
Q4 		– Sell
-66,400
Closed -$373K – 840
2015
Q3 		$373K Hold
66,400
– – 0.05% 429
2015
Q2 		$735K Buy
+66,400
New +$856K 0.1% 280
2014
Q2 		– Sell
-17,800
Closed -$321K – 723
2014
Q1 		$321K Buy
+17,800
New +$343K 0.05% 431

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spark Investment Management's SGMO Position: Q2 2018 in Review

Spark Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2018, closing a stake of 26,000 shares — an estimated $494K sold.

Spark Investment Management first reported a position in SGMO in Q1 2014 and held it in 6 quarters. The position peaked at $1.42M in Q4 2017. 210 funds tracked by Wall St. Rank hold SGMO as of Q2 2018.

  • Spark Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2018 after selling out during the quarter.
  • Spark Investment Management sold 26,000 SANGAMO THERAPEUTICS INC shares in Q2 2018, an estimated $494K.
  • Spark Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 6 quarters.
  • Spark Investment Management's SANGAMO THERAPEUTICS INC position peaked at $1.42M in Q4 2017.
  • 210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2018.

Based on Spark Investment Management's 13F filing for Q2 2018, filed 8 Aug 2018.